Type 1 diabetes

Type 1 diabetes is an autoimmune condition where the body's immune system attacks and destroys insulin-producing cells in the pancreas, leading to high blood sugar levels and requiring lifelong insulin therapy. Research highlights several important aspects of living with type 1 diabetes: cognitive function can be affected, regular exercise helps manage blood glucose levels, and vitamin D may play a role in disease management. Additionally, lipid metabolism is altered in people with type 1 diabetes, which has implications for cardiovascular health. Inflammation is a key factor in the development of type 1 diabetes, contributing to the destruction of insulin-producing cells. Teplizumab, a new drug, shows promise in delaying the onset of type 1 diabetes in at-risk individuals. The evidence base for some of these findings is still evolving and more research is needed to fully understand their implications.

Sources

• Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review. (PMID:28222533)
• Exercise and Type 1 Diabetes. (PMID:32342453)
• Mapping of Type 1 Diabetes Mellitus. (PMID:31584373)
• Type 1 Diabetes Mellitus and Vitamin D. (PMID:40429738)
• Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications. (PMID:36275658)
• Teplizumab: type 1 diabetes mellitus preventable? (PMID:37004543)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._